To identify risk factors for the onset and progression of uveal melanoma, an intraocular cancer that threatens both sight and life. Additionally, to identify biomarkers that predict response to treatment.

Who is Eligible

Individuals who have been newly diagnosed with uveal melanoma.

Subject Enrollment

We are currently enrolling individuals with eye melanoma who meet the study eligibility criteria.

Study Procedures

Qualified patients will provide blood specimens that will be stored and used for future analyses of clinical, genetic and molecular markers of uveal melanoma. Clinical data will also be obtained at the time of diagnosis and at regular intervals after diagnosis. Tumor tissue specimens will be obtained from patients who have the eye removed (called enucleation). These analyses will enhance our ability to develop measures that may reduce disease incidence and improve survival.